BioWorld Asia

Oct. 17, 2007

Look At Health Care Through Different Lens, P&G Advises

LONDON - Proctor and Gamble (P&G) is applying its expertise as a consumer products giant to get a patient's eye view of disease and use the insights to inform development programs with biotech partners. (BioWorld International) Read More

EuropaBio Takes Its Message To The Top

Genetic Screening For Bowel Cancer Risk Closer To Reality

Victoria Sets A Lofty Goal For Advancing Its Biotech

Cellectis and Servier Enter Cell Engineering Alliance

Other News To Note

Nobel Laureate's Interests Are As Broad As His Technology

Deals To M&As: The Culture Of False-Flagging, Shape-Shifting

Orexo Acquires A Pipeline In $133M Deal for Biolipox

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...